Skip to main content
Clinical Trials/NCT07240051
NCT07240051CompletedNot Applicable

Assessment of the Efficacy and Safety of 50% Glycolic Acid, 30% Salicylic Acid, and Modified Jessner's Chemical Peels in the Treatment of Active Acne and Post-acne Hyperpigmentation: Randomized Controlled Trial

Nahla Maher Mahmoud Mahran1 site in 1 country90 target enrollmentStarted: March 9, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
90
Locations
1
Primary Endpoint
improvement in acne vulgaris by assessing Global acne scoring system and post-acne hyperpigmentation index

Study Overview

Brief Summary

Assessment of the Efficacy and Safety of 50% Glycolic Acid, 30% Salicylic Acid, and Modified Jessner's Chemical Peels in the Treatment of Active Acne and Post-acne Hyperpigmentation: Randomized Controlled Trial.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
— to 65 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Facial active acne (mild and moderate cases)
  • •post-acne hyperpigmentation
  • •a minimum age of 18 years
  • •skin phototype III or IV

Exclusion Criteria

  • •Pregnant or nursing women
  • •active infection in the treatment area (e.g., verrucae and herpes simplex)
  • •systemic disease (hypertension, diabetes, or bleeding tendency)
  • •systemic retinoid or laser treatment within the last 6 months
  • •history of keloidal tendency or Aspirin sensitivity.

Arms & Interventions

glycolic acid group

Active Comparator

30 patients received 50% glycolic acid peels

Intervention: Glycolic acid peel alone (Procedure)

Modified Jessener group

Active Comparator

30 patients received MJ peel

Intervention: modified jessener (Procedure)

Salicylic acid group

Active Comparator

30 patients received Salicylic acid 30%

Intervention: salicylic acid (Procedure)

Outcomes

Primary Outcomes

improvement in acne vulgaris by assessing Global acne scoring system and post-acne hyperpigmentation index

Time Frame: 6 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Nahla Maher Mahmoud Mahran
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Nahla Maher Mahmoud Mahran

lecturer of Dermatology

Cairo University

Study Sites (1)

Loading locations...

Similar Trials